Abstract: Provided are control method and device of an energy-storage coordinated floating wind turbine, relating to the technical field of wind turbines. The control method of an energy-storage coordinated floating wind turbine can construct a primary frequency regulation model of a floating wind farm based on a frequency response unit, construct a second frequency regulation model according to an energy storage system, further construct, according to the primary frequency regulation model and the second frequency regulation model, a frequency regulation model of a hybrid power system containing the floating wind farm, the energy storage system, and a pre-set thermal power unit, and design an overall frequency regulation control strategy of the hybrid power system based on the frequency regulation model of the hybrid power system.

Abstract: The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or cancers. The recombinant oncolytic adenovirus is a selectively replicating oncolytic adenovirus, and the genome of the recombinant oncolytic adenovirus is integrated with a coding sequence of exogenous shRNA capable of inhibiting PDL1 expression in tumor cells. The replication capability of the virus in normal primary cells is much lower than the replication capability of the virus in tumor cells. Moreover, the expressed shPDL1 can significantly reduce the level of PDL1 protein highly expressed in tumor cells. Thus, the oncolytic killing effect of the oncolytic virus and the anti-tumor immunostimulatory effect of immune cells produce a synergistic effect.

Abstract: A test device for an automatic pressure regulating valve of an electronic braking system includes a test device composed of an air supply, a pneumatic circuit, a valve, a sensor, a signal processing unit, and a control unit. By subjecting an automatic pressure regulating valve to a bench test including a functional test, a static performance test, a dynamic performance test, an air tightness test, a leakage test, and a brake chamber braking force test, the present disclosure avoids the high risk of a field test, improves the test efficiency, and ensures the test consistency. An automatic pressure regulating valve is tested before being loaded on a vehicle, and parameters of the automatic pressure regulating valve are continuously modified through tests to improve the performance, such that the automatic pressure regulating valve can meet the real-time, fast, independent, and accurate regulation requirements of EBS of commercial vehicles.

Abstract: Disclosed herein are related to devices and methods for communication. In one aspect, a device includes a first processor and a second processor. The first processor may be configured to generate a first set of packets associated with an application data unit in a first layer corresponding to content data. Each packet of the first set of packets may include a flag indicative of an association with the application data unit. The second processor may be configured to generate a second set of one or more packets in a second layer for transmission, in response to determining that the first set of packets is associated with the application data unit according to flags of the first set of packets. The second processor may be configured to schedule to transmit the second set of one or more packets in the second layer within a defined time period.

Abstract: The present disclosure discloses an array substrate and a display device. The array substrate includes a touch substrate, the touch substrate includes a plurality of touch electrodes and a plurality of touch electrode wires disposed in an array, each touch electrode includes a plurality of touch sensors disposed in an array, common electrodes of all pixel cells of the array substrate are reused as the touch sensors, and the array substrate includes data wires for providing display data to the pixel cells; the array substrate includes a base substrate and a thin film transistor which are stacked, the touch electrode wires and the data wires are provided on the same layer where a source and a drain of the thin film transistor are located, and the touch electrode wires are abreast provided on the two sides of each data wire.

Abstract: A balance board for training and fitness that comprises a balance board body, a rolling ball or roller, and an adjusting component; the adjusting component comprises two arc-shaped adjusting parts and two vertical adjusting parts; when in use, the two arc-shaped adjusting parts and the two vertical adjusting parts cooperate to form a first movable space for adapting the rolling ball, the two arc-shaped adjusting parts cooperate to form a second movable space for adapting the rolling ball, and the two vertical adjusting parts cooperate to form a third movable space for adapting the roller. The two arc-shaped adjusting parts and two vertical adjusting parts can be used together or independently to form a plurality of movable spaces with different ranges, so that the swing amplitude of the balance board body can be adjusted to meet users with different training needs.

Abstract: A protocol processing method and apparatus, and a storage medium are provided. The method includes: carrying a leaf-transfer capability identifier in an RIFT protocol, the leaf-transfer capability identifier being configured to indicate that a first node that carries the leaf-transfer capability identifier supports other leaf nodes within a network to access the network through the first node.

Abstract: A balance board for training and fitness that comprises a balance board body, a rolling ball or roller, and an adjusting component; the adjusting component comprises two arc-shaped adjusting parts and two vertical adjusting parts; when in use, the two arc-shaped adjusting parts and the two vertical adjusting parts cooperate to form a first movable space for adapting the rolling ball, the two arc-shaped adjusting parts cooperate to form a second movable space for adapting the rolling ball, and the two vertical adjusting parts cooperate to form a third movable space for adapting the roller. The two arc-shaped adjusting parts and two vertical adjusting parts can be used together or independently to form a plurality of movable spaces with different ranges, so that the swing amplitude of the balance board body can be adjusted to meet users with different training needs.

Abstract: A therapeutic agent comprising a nucleic acid and a TCR modified immune cell and use thereof. The therapeutic agent comprises a first composition comprising a first active ingredient and a second composition comprising a second active ingredient. The first active ingredient includes or contains a nucleic acid having a labeling polypeptide coding sequence for being introduced into a tumor cell and/or a cancer cell. The labeling polypeptide has one or more epitope polypeptides which can be presented on a surface of the tumor cell and/or cancer cell by MHC class I molecules. The second composition comprises a second active ingredient in a second pharmaceutically acceptable carrier and the second active ingredient comprises a T cell receptor modified immune cell which can specifically recognize and bind to the epitope polypeptide presented by MHC class I molecules. The therapeutic agent achieves synergistic treatment effect and provides a new route for tumor treatment.

Abstract: The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or cancers. The recombinant oncolytic adenovirus is a selectively replicating oncolytic adenovirus, and the genome of the recombinant oncolytic adenovirus is integrated with a coding sequence of exogenous shRNA capable of inhibiting PDL1 expression in tumor cells. The replication capability of the virus in normal primary cells is much lower than the replication capability of the virus in tumor cells. Moreover, the expressed shPDL1 can significantly reduce the level of PDL1 protein highly expressed in tumor cells. Thus, the oncolytic killing effect of the oncolytic virus and the anti-tumor immunostimulatory effect of immune cells produce a synergistic effect.

Abstract: A therapeutic agent and method of administering the therapeutic agent for the treatment of tumors and/or cancers of a subject, the therapeutic agent comprising a first pharmaceutical composition comprising a first active ingredient in a first druggable vehicle, wherein the first active ingredient comprises a nucleic acid encoding a labelling polypeptide comprising one or more antigenic epitope peptides and/or encoding a MHC protein; a second pharmaceutical composition comprising a second active ingredient in a second druggable vehicle, wherein the second active ingredient comprises immune cells purified from peripheral blood or from tumor tissue and are cultured in vitro; wherein the nucleic acid when administered to the subject as part of the pharmaceutical composition causes the tumor cells and/or cancer cells of the subject to express the one or more antigenic epitope peptides to elicit an immune response of the immune cells.

Abstract: Provided are therapeutic agent including nucleic acid and CAR-modified immune cell and the use thereof. The therapeutic agent comprises first composition and second composition, the first composition comprises a nucleic acid having a labeling polypeptide coding sequence for being introduced into a tumor cell and/or a cancer cell; the labeling polypeptide has an extracellular antigen determining region, a spacer portion, and a transmembrane portion that are operatively linked, which can be expressed to form modification on the surface of the tumor cell and/or cancer cell; the extracellular antigen determining region comprises one or more epitope polypeptides; wherein, amino acid sequences of proteins on cell membrane or secreted proteins of mammal do not comprise the epitope polypeptide amino acid sequence in the natural state; the second composition comprises chimeric antigen receptor modified immune cell which specifically recognize and bind to the extracellular antigen determining region.

Abstract: A method for obstacle detection and recognition for an intelligent snow sweeping robot is disclosed, comprising: 1) disposing ultrasonic sensors at a front end of the snow sweeping robot to detect distance information from an obstacle ahead; and disposing radar sensors at the front and rear of the snow sweeping robot to detect whether a creature suddenly approaches; 2) processing signals detected by each of the ultrasonic sensors and radar sensors, and calculating a forward distance of the snow sweeping robot; and 3) determining a snow cover extent of a working road, detecting a change of the distance from the obstacles, and recognizing the obstacles for conditions of an ultrasonic ranging variation ratio and a variation of the forward distance of the snow sweeping robot, a change of the signal detected by radar sensors, and a descriptive statistic of the snow cover extent within a specific time period.

Abstract: A snow shovel structure of a snow plow robot. The snow shovel structure includes a housing where a snow shovel mechanism is. The snow shovel mechanism extends outside the housing and includes a first motor fixed on a top of the housing. The first motor is fixedly connected with a telescopic rod through an output shaft. A second motor is further provided on a top portion of an inner chamber of the housing, and a horizontal plate is fixedly arranged on a side wall of the inner chamber of the housing.

Abstract: Provided are an isolated recombinant oncolytic poxvirus capable of being regulated and controlled by microRNA and a use thereof. The isolated recombinant oncolytic poxvirus can be regulated and controlled by microRNA, and the expression level of the microRNA in tumor cells of a mammal is lower than that in normal cells of the same mammal. A target sequence of the microRNA is integrated in a 3?UTR region of an E10R gene in a recombinant oncolytic poxvirus genome.

Abstract: A wrist-mounted system for tracking hand poses includes one or more cameras mounted to a wearable band. In some examples, the one or more cameras are low profile and may be located less than 15 mm, and preferably less than 10 mm, of the wrist of the user. In some examples, a system includes a wearable band and one or more imaging sensors. The one or more imaging sensors are disposed to have a field of view that is anatomically distal when the wearable band is coupled to an arm of the user. The one or more imaging sensors each define an optical axis spaced from the wearable band of less than 15 mm, and preferably less than 10 mm. The image data may come from a single camera mounted on the back of the wrist which captures images of the surface contours of the back of the hand to infer hand poses and gestures.

Abstract: Disclosed is a snow shoveling and snow discharging assembly of a snow sweeping robot. The snow shoveling and snow discharging assembly comprises a snow stirring structure, a snow feeding structure and a snow raising structure. Stirring cutters in the snow stirring mechanism are driven by a stirring cutter shaft to stir bottom area snow into a snow feeding pipe of the snow feeding structure, an air blower in the snow feeding structure blows accumulated snow into a snow raising pipe of the snow raising structure through a connecting pipe, the snow raising pipe can be driven by a steering motor to rotate by a certain angle to control the snow raising direction, and a second electric push rod acts to control pitching of the guide part, so that the height of snow during snow raising is controlled.

Abstract: The present disclosure provides therapeutic agents comprising oncolytic vaccinia viruses and NK cells, and uses thereof for preparation of drugs for treatment of tumors and/or cancers. The active ingredients of the therapeutic agents comprise an oncolytic vaccinia virus and NK cells, wherein the oncolytic vaccinia virus can selectively replicate in tumor cells.